List of insiders holdings for Kiniksa Pharmaceuticals Ltd.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 2023-06-08 17:37:50 | 29,680 2,824,287 | 2,853,967 | Form 4 |
| Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare GP LLC Cormorant Global Healthcare Master Fund LP 10% Owner | 2019-02-14 16:14:48 | 831,000 0 | 831,000 | Form 13G |
| Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP CORMORANT PRIVATE HEALTHCARE FUND I LP Chen Bihua 10% Owner | 2019-02-14 16:14:48 | 831,000 0 | 831,000 | Form 13G |
| BOESS CARSTEN 10% Owner | 2018-05-29 19:19:09 | 559,016 0 | 559,016 | Form 4 |
| Patel Sanj K CHAIRMAN & CEO | 2024-04-08 17:22:24 | 291,556 109,795 | 401,351 | Form 4 |
| Tessari Eben CHIEF OPERATING OFFICER | 2024-04-08 17:17:17 | 189,781 0 | 189,781 | Form 4 |
| Paolini John F. CHIEF MEDICAL OFFICER | 2024-04-08 17:21:19 | 111,000 0 | 111,000 | Form 4 |
| Mahoney Stephen F. President & COO | 2019-09-19 16:18:37 | 82,000 0 | 82,000 | Form 4 |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-04-08 17:19:24 | 79,058 0 | 79,058 | Form 4 |
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-04-08 17:20:25 | 77,549 0 | 77,549 | Form 4 |
| Malley Thomas Director | 2023-07-03 16:15:18 | 5000 71,967 | 76,967 | Form 4 |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-04-08 17:18:26 | 70,540 0 | 70,540 | Form 4 |
| Heberlig Chris EVP & CFO | 2019-09-19 16:16:52 | 50,000 0 | 50,000 | Form 4 |
| Pano Arian Chief Clinical Dev. Officer | 2021-09-07 17:19:21 | 27,213 0 | 27,213 | Form 4 |
| Levy Richard S Director | 2023-11-07 16:33:10 | 10,554 0 | 10,554 | Form 4 |
| Beetham Thomas W. EVP & Chief Legal Officer | 2021-03-23 17:32:56 | 10,142 0 | 10,142 | Form 4 |
| Rizvi Qasim Chief Commercial Officer | 2021-01-05 17:07:03 | 5176 0 | 5176 | Form 4 |
| Quart Barry D Director | 2023-07-03 16:15:04 | 5000 0 | 5000 | Form 4 |
| McCain Tracey L Director | 2023-07-03 16:15:16 | 5000 0 | 5000 | Form 4 |
| Popovits Kimberly J Director | 2023-07-03 16:15:12 | 5000 0 | 5000 | Form 4 |
| Cole G Bradley Director | 2023-07-03 16:15:09 | 5000 0 | 5000 | Form 4 |
| Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. *Possible member of 10% group 10% Owner | 2020-02-13 12:42:47 | 0 0 | 0 | Form 13G |
| Biggar Stephen R Director | 2018-05-23 20:23:42 | 0 0 | 0 | Form 3 |